Invitae Corporation has launched the Invitae Carrier Screen, an affordable test designed to inform prospective parents of genetic changes that…
Ana de Barros, PhD
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
A new U.S. Centers for Disease Control and Prevention (CDC) report found a 15% increase in the prevalence of autism…
Lysogene has signed a partnership agreement with Hervé Moine, a pioneering French researcher, to potentially develop a gene therapy…
A University of Delaware researcher is helping people with intellectual disabilities overcome the challenges of physical fitness by developing programs…
During Autism Awareness Month in April, the nonprofit FRAXA Research Foundation and shoelace company U-Lace established a new partnership to help fund…
The U.S. Food and Drug Administration (FDA) recently accepted the investigational new drug (IND) application for BPN14770, a small molecule therapeutic…
Boston-based FDNAÂ has launched a global initiative to promote medical research collaborations and to develop new precision approaches for diagnosing…